Adaptation of dose-prescription for vestibular schwannoma radiosurgery taking body contouring method and heterogeneous material into account
- PMID: 40008908
- PMCID: PMC11884334
- DOI: 10.2340/1651-226X.2025.41924
Adaptation of dose-prescription for vestibular schwannoma radiosurgery taking body contouring method and heterogeneous material into account
Abstract
Background: Majority of vestibular schwannoma (VS) patients have undergone gamma-knife radiosurgery (GKRS) with favorable results. Clinical evidence is derived from doses calculated with a type-a algorithm, which in this case assumes all material to be water. A type-b algorithm (Convolution algorithm [CA]) taking tissue heterogeneity into account is available. Historically, body contour is defined using a 16-point approximation, whereas modern softwares generate the body from Magnetic Resonance Imaging (MRI). The accuracy in dose-calculation algorithms (DCA) and contouring method (CM) will have a significant influence in the relation between clinical outcome and dosimetric data. The objective was to investigate the impact of DCA and CMs on dose distribution while preserving treatment conditions.
Methods: Treatment plans for 16 VS patients were recalculated in terms of DCA and CM. The difference in the dose covering 99% of the VS (DVS99%) depending on CM and DCA was estimated. The difference in DVS99% was used to adopt the prescription of new CA-based plans. CA-plans were recalculated to TMR10 to evaluate clinical treatability, as clinical evidence is derived from TMR10-doses.
Results: Both CM and DCA had a significant impact on the dose to VS and surrounding structures. CM altered the doses homogenously by 2.1-3.3%, whereas DCA heterogeneously by 5.0-10.7%. An increase of 9.1[8.1, 10.0]% was found for DVS99% and the CA-plans recalculated into TMR10 resulted in clinically treatable plans.
Interpretation: We conclude that transferring to more modern algorithms that take tissue heterogeneity into account heterogeneously alter dose distributions. This work establishes a safe pathway to adopt prescription dose for VS while preserving clinical treatability.
Conflict of interest statement
The authors report there are no competing interests to declare.
Figures
References
-
- Elekta AB. The Convolution Algorithm in Leksell GammaPlan® 10 Technical Report no. 018881.01. Stockholm: Elekta AB; 2011b.
-
- Pantelis E, Logothetis A, Zoros E, Pappas EP, Papagiannis P, Paddick I, et al. Dosimetric accuracy of the Convolution algorithm for Leksell Gamma Plan radiosurgery treatment planning: evaluation in the presence of clinically relevant inhomogeneities. J Appl Clin Med Phys. 2023;24(5):e13903. 10.1002/acm2.13903 - DOI - PMC - PubMed
-
- Wilke L, Andratschke N, Blanck O, Brunner TB, Combs SE, Grosu AL, et al. ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. 2019;195(3):193–8. 10.1007/s00066-018-1416-x - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
